Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 319
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 2024 Bonanno, LauraDal Maso, AlessandroPavan, AlbertoPasello, GiuliaGuarneri, Valentina + FRONTIERS IN IMMUNOLOGY - -
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 2024 Dieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaGuarneri, Valentina + JOURNAL OF THE NATIONAL CANCER INSTITUTE - -
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients 2024 Bonanno, LauraDal Maso, AlessandroGuarneri, ValentinaPasello, Giulia + FRONTIERS IN IMMUNOLOGY - -
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 2024 Boscolo Bragadin, AndreaGuarneri, ValentinaBonanno, LauraIndraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer 2024 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs) 2024 Guarneri, Valentina + CANCER TREATMENT REVIEWS - -
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 2024 Bonanno, LauraZingone, FabianaBarberio, BrigidaDal Maso, AlessandroPasello, GiuliaDei Tos, Angelo PaoloFassan, MatteoSavarino, Edoardo VincenzoGuarneri, Valentina + THE ONCOLOGIST - -
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 2024 Pasello, GiuliaSalizzato, ValentinaPiccin, LuisaBonanno, LauraGuarneri, Valentina + JOURNAL OF TRANSLATIONAL MEDICINE - -
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies 2024 Marinato, Gian MarcoPasello, GiuliaGuarneri, ValentinaBonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 2023 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaVernaci, GraziaGuarneri, ValentinaDieci, Maria Vittoria + BRITISH JOURNAL OF CANCER - -
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial 2023 Dieci, Maria VittoriaConte, PierfrancoGuarneri, Valentina + NPJ BREAST CANCER - -
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 2023 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + INTERNATIONAL JOURNAL OF CANCER - -
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 2023 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread 2023 Guarneri, Valentina + CANCER TREATMENT REVIEWS - -
News from the San Antonio Breast Cancer Symposium 2022 2023 Guarneri, Valentina + BREAST CARE - -
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY 2023 Guarneri, Valentina + BREAST CANCER RESEARCH AND TREATMENT - -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 2023 Menichetti, AliceGriguolo, GaiaGiorgi, Carlo AlbertoGuarneri, ValentinaDieci, Maria Vittoria + NPJ BREAST CANCER - -
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases 2023 Griguolo, GaiaGuarneri, Valentina + THE BREAST - -
Mostrati risultati da 1 a 20 di 319
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile